|
|
| Product N° |
Productname |
Quantity |
Price (EUR) |
Tech sheet |
|
|
BC-026
|
CART Peptide (55-102), Human
|
100 ug
|
358
|
|
|
|
BC-025
|
CART Peptide (55-102), Rat
|
100 ug
|
358
|
|
|
|
AE-001
|
Caspase Inhibitor Negative Control (Cathepsin B Inhibitor) (Z-FA-FMK)
|
5 mg
|
304
|
|
|
|
AD-012
|
Caspase Inhibitor Negative Control / Biotin Tag (Cathepsin B Inhibitor / Biotin Tag) (Biotin-FA-FMK)
|
5 mg
|
443
|
|
|
|
AB-028
|
Caspase Inhibitor Q-VD-OPH
|
5 mg
|
714
|
|
|
|
AC-021
|
Caspase-1 / ICE Fluorogenic Substrate 1 (Ac-VAD-AFC)
|
5 mg
|
324
|
|
|
|
AC-001
|
Caspase-1 / ICE Fluorogenic Substrate 2 (Ac-YVAD-AFC)
|
10 mg
|
355
|
|
|
|
AB-011
|
Caspase-1 / ICE Inhibitor 2 (Z-YVAD-FMK)
|
3 mg
|
537
|
|
|
|
BC-116
|
Caspase-1, human recombinant, active
|
25 U
|
321
|
|
|
|
BC-117
|
Caspase-1, human recombinant, active
|
100 U
|
466
|
|
|
|
AB-009
|
Caspase-1,4,5 Inhibitor (Z-WEHD-FMK)
|
1 mg
|
309
|
|
|
|
AC-029
|
Caspase-1,4,5 Substrate -pNA (Ac-WEHD-pNA)
|
25 mg
|
459
|
|
|
|
AB-024
|
Caspase-1/ICE Inhibitor 2 -CHO (Ac-YVAD-CHO)
|
5 mg
|
299
|
|
|
|
AC-023
|
Caspase-1/ICE Substrate 2-pNA (Ac-YVAD-pNA)
|
25 mg
|
495
|
|
|
|
AC-064
|
Caspase-1/ICE Substrate pNA (Ac-VAD-pNA)
|
25 mg
|
428
|
|
|
|
AB-021
|
Caspase-13 Inhibitor (Z-LEED-FMK)
|
3 mg
|
518
|
|
|
|
AC-008
|
Caspase-2, 3 Fluorogenic Substrate (Ac-VDVAD-AFC)
|
5 mg
|
353
|
|
|
|
AB-008
|
Caspase-2, 3 Inhibitor (Z-VDVAD-FMK)
|
3 mg
|
710
|
|
|
|
AC-007
|
Caspase-6 Fluorogenic Substrate (Ac-VEID-AFC)
|
10 mg
|
442
|
|
|
|
BC-115
|
Cerulenin
|
50 mg
|
504
|
|
|
|
AB-007
|
Caspase-6 Inhibitor (Z-VEID-FMK)
|
3 mg
|
621
|
|
|
|
AC-003
|
Caspase-3 / CPP32 Fluorogenic Substrate (Ac-DEVD-AFC)
|
10 mg
|
397
|
|
|
|
EN-004
|
Caspase-3
|
5 µg
|
325
|
|
|
|
BC-255
|
Chetomin
|
1 mg
|
284
|
|
|
|
AC-027
|
Caspase-2,3 Substrate -pNA (Ac-VDVAD-pNA)
|
25 mg
|
441
|
|
|
|
AB-026
|
Caspase-8/FLICE Inhibitor-CHO (Ac-IETD-CHO)
|
5 mg
|
299
|
|
|
|
AC-004
|
Caspase-8 / FLICE Fluorogenic Substrate (Ac-IETD-AFC)
|
5 mg
|
282
|
|
|
|
AC-028
|
Caspase-4,5,9 Substrate -pNA (Ac-LEHD-pNA)
|
25 mg
|
484
|
|
|
|
EN-005
|
Caspase-7
|
5 µg
|
325
|
|
|
|
AB-025
|
Caspase-3/CPP32 Inhibitor -CHO (Ac-DEVD-CHO)
|
5 mg
|
299
|
|
|
|
BC-120
|
Caspase-4, human recombinant, active
|
25 U
|
298
|
|
|
|
AC-024
|
Caspase-3/CPP32 Substrate-pNA (Ac-DEVD-pNA)
|
25 mg
|
387
|
|
|
|
BC-125
|
Caspase-9, human recombinant
|
100 U
|
428
|
|
|
|
BC-118
|
Caspase-2, human recombinant, active
|
25 U
|
298
|
|
|
|
BC-123
|
Caspase-5, human recombinant, active
|
100 U
|
451
|
|
|
|
BC-124
|
Caspase-9, human recombinant, active
|
25 U
|
321
|
|
|
|
AD-003
|
Caspase-3 / CPP32 Inhibitor / Biotin Tag (Biotin-DEVD-FMK)
|
1 mg
|
409
|
|
|
|
AB-010
|
Caspase-4,5,9 Inhibitor (Z-LEHD-FMK)
|
1 mg
|
309
|
|
|
|
EN-002
|
Caspase-6, human recombinant
|
5 µg
|
310
|
|
|
|
BC-119
|
Caspase-2, human recombinant, active
|
100 U
|
451
|
|
|
|
AB-003
|
Caspase-3 / CPP32 Inhibitor (Z-DEVD-FMK)
|
5 mg
|
884
|
|
|
|
AC-025
|
Caspase-8 Substrate-pNA (Ac-IETD-pNA)
|
25 mg
|
405
|
|
|
|
AB-027
|
Caspase-6 Inhibitor-CHO (Ac-VEID-CHO)
|
5 mg
|
299
|
|
|
|
BC-121
|
Caspase-4, human recombinant active
|
100 U
|
451
|
|
|
|
AB-004
|
Caspase-8/FLICE.
|
3 mg
|
617
|
|
|
|
EN-003
|
Caspase-8
|
5 µg
|
325
|
|
|
|
BC-027
|
CD40L, human recombinant
|
50 ug
|
703
|
|
|
|
BC-122
|
Caspase-5, human recombinant, active
|
25 U
|
298
|
|
|
|
AC-026
|
Caspase-6 Substrate-pNA (Ac-VEID-pNA)
|
25 mg
|
436
|
|
|
|
AC-010
|
Caspase-4,5,9 Fluorogenic Substrate (Ac-LEHD-AFC)
|
5 mg
|
311
|
|
|